1. Moreno-Ramírez D, Raya-Maldonado J, Morales-Conde M, Ojeda-Vila T, Martín-Gutiérrez FJ, Ruíz-de-Casas A, et al. Increasing Frequency of Seborrheic Keratosis Diagnoses as a Favorable Consequence of Teledermatology-Based Skin Cancer Screening: A Cross-sectional Study of 34,553 Patients. Am J Clin Dermatol. 2017;18(5):681–5.
2. Ford JA, Pereira A. Does teledermatology reduces secondary care referrals and is it acceptable to patients and doctors?: a service evaluation. J Eval Clin Pract. 2015;21(4):710–6.
3. Izikson L, Sober AJ, Mihm MC Jr, Zembowicz A. Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases. Arch Dermatol. 2002;138(12):1562–6.
4. Duque MI, Jordan JR, Fleischer AB, Williford PM, Feldman SR, Teuschler H, et al. Frequency of seborrheic keratosis biopsies in the United States: a benchmark of skin lesion care quality and cost effectiveness. Dermatol Surg. 2003;29(8):796–801.
5. Chen TY, Morrison AO, Cockerell CJ. Cutaneous malignancies simulating seborrheic keratoses: An underappreciated phenomenon?. J Cutan Pathol. 2017;44(9):747–8.